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Amikacin, Ceftazidime, and Flucloxacillin against Suspended and Adherent
Pseudomonas aeruginosa and Staphylococcus epidermidis in an In Vitro Model
of Infection
Patrice Vergeres and J iirg Blaser Divisions ofInfectious Diseases and Medica/Informatics, Department of
Medicine, University Hospita/, Zurich, Switzerland
Bacterial inocula were exposed as suspended cultures or as adherent biofilms on glass beads in
a novel in vitro model of infection to oscillating drug concentrations mimicking human serum
kinetics during clinical treatment. Amikacin was given once or thrice daily alone or in combina-
tion with ceftazidime or flucloxacillin against Pseudomonas aeruginosa or Staphylococcus epider-
midis. Killing of adherent bacteria was significantly reduced during single-drug treatment com-
pared with suspended bacteria (P < .001), and fj-Iactams were more active than amikacin against
both suspended and adherent bacteria (P < .01), Amikacin-fj-Iactam combinations killed the
inocula more rapidly and were consistently bactericidal against both suspended and adherent
pathogens (P < .05). Once-daily dosing of amikacin produced greater initial killing than thrice
daily dosing (P < ,05), but both regimens were similarly effective after 48 h. The differences in
antibiotic activity against suspended and adherent bacteria may relate to clinical failures in the
treatment of foreign-body infections by bacteria sensitive to the administered antibiotics, as
determined by standard susceptibility tests.
Antibiotic treatments of foreign-body infections without
removal of the infected implants often fail even if the patho-
gens are highly susceptible as determined by standard in vi-
tro tests [l, 2]. It has been suggested that the mode ofgrowth
of bacteria adhering to metallic or polymeric implants and
the formation of a biofilm by bacterial secretion of extracel-
lular glycocalix may explain such failures [3-6]. It has also
been advocated that restricted drug penetration through
thick bacterial biofilms may limit therapeutic efficacy ofanti-
biotics during treatment of other than implant-related infec-
tions, such as osteomyelitis or endocarditis [7, 8].
Various animal models of implant-associated infections
have been used to search for effective antimicrobial treat-
ment of foreign-body infections [9, 10]. Recently, in vitro
studies also considered the effect of constant concentrations
of antibiotics against both adherent and suspended bacteria
[11, 12]. However, in vitro models of bacterial infection ex-
posing bacteria to fluctuating concentrations ofantibiotic ac-
cording human pharmacokinetics have been limited so far to
the study of suspended cultures [13, 14].
This study presents a novel pharmacodynamic model that
considers quantitatively the activity of antimicrobial agents
against both adherent and suspended bacteria, mimicking
prolonged bacterial exposure to oscillating drug levels ac-
cording to human serum kinetics.
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Materials and Methods
In vitro model. A one-compartment pharmacokinetic model
that provides exposure ofbacteria to changing concentrations of
antimicrobial agents was used. In contrast to previously de-
scribed in vitro models, the design of the culture compartment
of this model allows for periodic assessment of the bactericidal
effect against both adherent and suspended bacteria. Figure I is
a schematic diagram of the model, including a cross-section
through a 17-ml culture compartment. During the experiment
with adherent bacteria, glass beads covered with a bacterial bio-
film were added to a wire cage within the compartment for inocu-
lation. Subsequently these beads were removed at various sam-
pling times. During each experiment, three models inoculated
with suspended cultures and three with adherent inocula were
set up simultaneously.
The system was filled with tryptic soy broth (TSB) supple-
mented with 50 f.Lg ofCaz+/ml and 25 f.Lg ofMgz+/ml (TSB-S). A
peristaltic pump continuously transported antibiotic-free broth
from the reservoir into the compartment. Antibiotic doses ad-
ministered into the culture compartments were eliminated expo-
nentially, due to continuous perfusion of the compartment.
Concentration-time profiles were achieved according to human
serum kinetics by defining the flow rate of the pump (clearance,
CI) in function of the volume of the culture compartment (V)
and the elimination half-life (t I/Z ) as CI = In2 X V/t 1IZ '
Dosage regimens. Antibiotic doses were chosen to achieve
drug concentrations similar to mean concentrations achieved
clinically in patients during administration of daily doses of 3 g
of ceftazidime or flucloxacillin (floxacillin) or 15 mg/kg amika-
cin. The following drug regimens were tested either alone or in
combination over a 48-h period: (I) ceftazidime regimen, given
as a loading dose to rapidly achieve a steady-state concentration
of 16 mg/I followed by a 48-h continuous infusion; (2) flucloxa-
cillin regimen, given as loading dose to rapidly achieve a steady-
state concentration of 2 mg/I followed by a 48-h continuous
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Figure 1. Schematic drawing of one-compartment kinetic
model. Inocula ofPseudomonas aeruginosa and Staphylococcus epi-
dermidis were added to culture compartment as suspended bacte-
rial cultures or as biofilms ofbacteria adhering to beads. Beads were
removed from time to time from compartment with surgical forceps
after opening tightly sealed port. Amikacin was administered into
compartment as I-h infusions and removed exponentially due to
continuous dilution with drug-free medium.
infusion; (3) regimen Aq24, a I-h infusion of amikacin at 0 h
and 24 h to provide peak concentrations of72 mg/I and troughs
of <0.1 mg/I, according to a 2-h elimination half-life; and (4)
regimen Aq8, I-h infusions of amikacin given every 8 h with an
initial peak concentration of 24 mg/I and a trough level of 2
mg/I, according to a half-life of2 h. Concentrations ofamikacin
achieved in the culture compartment were measured by fluores-
cence polarization immunoassay (TDx; Abbott Laboratories,
Abbott Park, IL). The differences between the measured and the
calculated concentrations averaged 6% (mean of 24 measure-
ments). Amikacin was administered by a syringe infusion pump.
Continuous infusions of ceftazidime and flucloxacillin were
achieved by adding the drug to sterile broth kept at room temper-
ature outside the 37°C incubator.
Bacteria. Four strains were used: Pseudomonas aeruginosa
ATCC 27853 and S64, a clinical isolate from a cystic fibrosis
patient, and Staphylococcus epidermidis V2, slime-producing
[15] (provided by G. Peters, Cologne, Germany), and B3972, a
clinical isolate [I]. MICs were determined by broth dilution tech-
nique, using inocula of -- 5 X 105 colony-forming units (cfu)/ml
in 2-ml volumes. MBCs were determined as >99.9% killing of
the bacterial inocula. Quantitative subcultures were obtained of
each tube by filtering 100-JLI volumes through membrane filters
with 0.45-JLm pore size (Sartorius, Gottingen, Germany) and
subsequently culturing the filters on agar. For both strains of P.
aeruginosa, the MICs were 8 mg/l for amikacin and 4 mg/I for
ceftazidime. The MICs for S. epidermidis V2 were I mg/l for
amikacin and 0.25 mg/I for flucloxacillin and for strain B3972,
8 mg/l for amikacin and I mg/l for flucloxacillin. All MBCs
were either identical to the MICs or twofold higher.
MICs were also determined with inocula from released adher-
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ent bacteria. These inocula were obtained by vortexing beads
covered with bacterial biofilms to remove the adherent popula-
tion from the surface and bring the bacteria into suspension. All
MICs were identical except for twofold higher results obtained
with amikacin against P. aeruginosa S64 and S. epidermidis V2
and B3972.
Suspended inocula. Volumes of 0.6-1 ml of overnight cul-
tures were added to 17 ml of broth within the culture compart-
ments 30 min before drug administration, yielding mean inoc-
ula of suspended bacteria of 4.3 X 106 cfu/ml. For each strain,
the suspended inocula were adjusted to achieve total numbers of
suspended bacteria within the compartments ofabout two times
higher than the bacterial numbers inoculated by adherent bio-
films. Thus, lower activity against adherent inocula did not re-
late to an inoculum effect.
To study the effect of amikacin treatment against bacteria in
the stationary phase of growth, TSB-S as the culture medium
was completely replaced in the in vitro model by 0.25% glucose-
supplemented PBS, pH 7.4 (PBS-S). Volumes of 0.8 ml over-
night culture in TSB-S were cooled in a syringe in 20 min from
37°C to --4°C and subsequently added to 17 ml of PBS-S
within the culture compartments 30 min before drug adminstra-
tion.
Adherent inocula. Sterile solid glass beads (diameter, 2-3
mm) or sinter glass beads containing pores of60-300 JLm (Sikug
023/300/A; Schott Schleifer, Muttenz, Switzerland) were
placed into 20-ml cultures of TSB-S that were inoculated with
two colonies taken from a blood agar plate and incubated over-
night. The solid glass beads were removed from the overnight
cultures and placed into 25 ml of sterile saline solution (0.9%
NaCl) for washing off bacteria suspended within the broth
carried over. Overnight broth was separated from sinter glass
beads by placing the beads on filters and rinsing them with 10
ml of sterile saline solution. The culture compartments of the
model were inoculated with 12 solid or sinter glass beads that
were placed into the compartments with a sterile surgical for-
ceps.
Quantification of bactericidal activity. During the experi-
ments with suspended bacterial inocula, 0.3-ml specimens of
the culture medium were sampled from each culture compart-
ment seven times within the 48-h treatment period (at 0, 2, 6,
24,26, 30, and 48 h) to document the number of suspended cfu
over time. During experiments with adherent bacterial inocula,
0.3-ml specimens of the culture medium and one bead were
removed from the culture compartment at each of the seven
sampling points with a sterile surgical forceps. This bead was
placed into a tube containing 2 ml of sterile broth. Bacteria
adhering to the glass bead were removed by vigorously vortexing
the tube three times for 15 s. Longer vortexing or additional
treatment in an ultrasonic bath increased the cfu counts by <2%.
In addition, tubes containing the beads were incubated for 48 h.
Eradication of the adheren t bacterial inocula was defined as
tubes showing no visible growth after 48 h of incubation.
Specimens of the broth in which the beads had been vortexed
were subsequently processed similarly to specimens withdrawn
directly from the culture compartments. Each sample was di-
luted 1OO-fold and subcultured on tryptic soy agar plates using a
spiral plater (Spiral System Instruments, Bethesda, MD). In ad-
dition, 100 JLl of each sample was filtered through a membrane
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Figure 2. Control growth curves in absence ofany antibiotics for
Staphylococcus epidermidis V2 and Pseudomonas aeruginosa S64 in
one-compartment in vitro model. Inocula were administered as sus-
pended cultures (colony-forming units per milliliter [cfu/ml] in
broth) or as bacterial biofilm adhering to glass beads (cfu/ml shed
bacteria suspended in broth and cfu ofadherent bacteria per sinter
glass bead). Geometric means and SD of two replicates are shown.
filter of 0.45-~m pore size. Subsequently the filters were placed
on agar and incubated at 37°C. Bacterial colonies growing on
the agar were counted (Laser Bacteria Colony Counter model
500A; Spiral System Instruments), and the number of cfu per
milliliter (cfu/ml) was calculated. The incubation time varied
from 16 to 48 h hours, depending on the strain and whether the
specimens were plated directly on agar or subcultured on a filter.
Control growth curves in the absence of any drug were also
obtained for both adherent and suspended inocula with all
strains. Figure 2 shows curves for S. epidermidis V2 and P. aeru-
ginosa S64. Similar results were obtained with the two other
strains. The limited initial decrease ofadherent cfu was observed
with both strains of P. aeruginosa but not with S. epidermidis.
Assessment ofremoval ofadherent bacteria. Both sterile solid
Staphylococcus epidermidis V2
Suspended inocula ofP. aeruginosa. Treatment with ami-
kacin alone produced an initial killing (mean reduction of
both strains after 6 h) of 4.2 10giO during Aq8 regimens and
>5 log during Aq24 regimens. However, strain 27853 regrew
to bacterial densities of -- 104 cfu/ml within 24 h of treat-
ment with either regimen. No bactericidal effect occurred
Results
and sinter glass beads were placed in 2 ml of TSB-S containing
20 ~Ci of [3H]thymidine (specific activity, 29 Ci/mmol; Amer-
sham Laboratories, Amersham, UK). After inoculation with
one colony taken from a blood agar plate, these cultures were
incubated overnight. Then beads were removed from cultures,
placed on filters, and rinsed with sterile saline solution (0.9%
NaCl) to remove suspended bacteria and unincorporated
[3H]thymidine. Three beads were transferred to three scintilla-
tion vials each containing 3 ml of scintillant (Opti-Fluor; Pack-
ard Instruments, Downers Grove, IL). Another three beads were
placed in three tubes each containing 2 ml ofsterile broth. Bacte-
ria adhering to the beads were removed from the beads by vigor-
ously vortexing the tubes three times for 15 s. Samples (1 00 ~l)
of the broth were transferred to the vials containing scintillant.
In addition, the beads were washed on filters to remove sus-
pended bacteria in broth and also transferred to scintillation
vials. The amount of radioactivity retained on beads and in
broth was measured with a liquid scintillation analyzer
(2200CA; Packard Instruments). Controls with sterile beads in
broth without radiolabeled thymidine were also measured in
triplicate. In addition, removal of unincorporated [3H]_
thymidine from beads by the washing and vortexing procedure
was controlled in overnight samples without bacteria. Similar
results were obtained with both control methods. The counts
per minute (cpm) of three vials were averaged, and cpm ofcon-
trol beads without radiolabeled thymidine were subtracted. The
remaining radioactivity on beads after vortexing was compared
with the activity before vortexing to determine the efficacy of
removal by vortexing.
Postexposure susceptibility testing. Subpopulation analysis
was done during experiments with ceftazidime against adherent
inocula of P. aeruginosa S64 and with amikacin (Aq8) against
adherent inocula ofS. epidermidis V2. Samples ofadherent bac-
teria (released from the beads by vortexing) and suspended bac-
teria shed from the biofilm were diluted appropriately and were
cultured on TSB agar plates containing no antibiotics and plates
containing 1, 4, or 16 mg/l amikacin or 4, 8, or 16 mg/l ceftazi-
dime.
Data analysis. Geometric means were used to describe the
average number of cfu determined in multiple experiments. If
no cfu were detected in a 1OO-~l sample, a value of 10 cfu/ml
was arbitrarily used for the calculation of the geometric mean.
Response during the initial 6-h treatment period and during the
total 48-h treatment period was analyzed by logarithmic trans-
formation of the cfu data followed by analysis of variance. Fur-
ther comparisons were done by the Scheffe F test. Initial dose
response (0-6 h) was compared with response ofdoses after 24 h
of treatment (24-30 h) for each treatment with the paired t test
(figure 3). Percentage of resistant subpopulations was studied by
analysis of variance after logarithmic transformation.
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Figure 3. Effect of amikacin administered once (thick .lines) or
trice daily (thin lines) against Pseudomonas aeruginosa 27853 in
one-compartment in vitro model. Bactericidal activity was studied
in experiments with either suspended (solid lines) or adherent inoc-
ula (broken lines, adherent colony-forming units recovered from
beads). In contrast to first dose, doses administered after 24 h
showed significantly less bactericidal activity (P < .0 I). Geometric
means and SO of two or three replicates are shown.
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27853 were initially reduced by 3.1 log (figure 3). Doses
given after 24 h with the Aq8 regimen showed almost no
bactericidal effect with either strain (0.1-0.4 log killing, fig-
ure 4). Regimen Aq24 reduced the adherent bacteria ofboth
strains within the first 6 h by 3.4 and 3.5 log, respectively
Figure 4. Effect of amikacin (thrice daily), ceftazidime (loading
dose followed by continuous infusion), and combination of both
drugs against Pseudomonas aeruginosa S64 in one-compartment in
vitro model. Significantly (P < .0 I) better early bactericidal activity
was observed in experiments using initial inoculum of suspended
bacteria (colony-forming units per milliliter [cfujml] in broth)
compared with results using initial inoculum of bacteria adherent
to glass beads (cfujml shed from solid glass beads and suspended in
broth and cfu adhering to each sinter glass bead). Geometric means
and SO of two or three replicates are shown.
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with strain 27853 after the dose given after 24 h during the
Aq8 regimen. In contrast, the second dose during once-daily
treatment still reduced the count ofcfu/ml from 2.5 X 104 at
24 h to 35 at 30 h (figure 3). Strain S64 showed no regrowth
within the first 24 h of treatment with both regimens, despite
the prolonged period of subinhibitory concentrations of 17 h
before administration of the second dose with regimen Aq24
(figure 4). However, both strains did regrow within the 48-h
treatment period with either dosing schedule. Ceftazidime
alone produced rapid initial killing of P. aeruginosa S64
(>4.4 log reduction within 6 h, figure 4). Strain 27853 was
killed slower ( 1.5 log) despite identical MICs ofboth strains.
However, after 48 h of treatment, both strains were reduced
below the detection limit in four of five experiments (in one
experiment with strain 27853, 2.3 X 102 cfu/ml were found).
The combination regimens produced more rapid initial kill-
ing « 10 cfu/ml after 6 h) ofboth strains with no subsequent
regrowth (figure 4).
Adherent inocula of P. aeruginosa. Adherent bacteria of
P. aeruginosa S64 showed no response to treatment with the
Aq8 regimen (figure 4); there was no significant difference
detectable between this regimen and the control growth
curve (figure 2). In contrast, adherent bacteria of strain
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(figure 3). The second dose given after 24 h was less effec-
tive. Strain S64 showed nearly no response to the second
dose (0.3 log killing), and strain 27853 was reduced by 1.8
log (figure 3). Both strains responded similarly to single-
agent treatment with ceftazidime: Adherent bacteria were
killed continuously but very slowly, resulting in a reduction
of only 2.3 log for strain S64 (figure 4) and 1.2 log for strain
27853 after 48 h. However, combinations of ceftazidime
with either Aq8 or Aq24 produced rapid initial killing of
adherent bacteria of both strains, and no subsequent re-
growth occurred (table 1).
Although inocula were administered as biofilms of bacte-
ria adhering to glass beads, bacteria were also found in sus-
pension due to continuous shedding ofcells from the biofilm
into the liquid culture medium. The initial response to the
Aq8 and Aq24 regimens observed during these experiments
against shed suspended bacteria (in the presence ofbiofilm-
covered glass beads) were 0.8 and 4.6 log killing after 6 h
with strain S64 and 3.0 and 5.1 log killing with strain 27853,
respectively (figure 4). Both strains regrew also in suspension
with either amikacin regimen. In contrast, ceftazidime ad-
ministered alone killed shed suspended P. aeruginosa S64
rapidly (3.6 log reduction after 6 h), followed by a steady
decline during the remaining 42 h. Shed cells of P. aerugi-
nosa 27853 were killed less rapidly by ceftazidime. The ini-
tial effect was limited to 1.2 log reduction, and after 48 h of
treatment there were still 1000 cfu/ml present. Combina-
tions of ceftazidime and amikacin Aq8 or Aq24 synergisti-
cally killed shed suspended bacteria. Strain S64 was reduced
below the sensitivity limit after 6 h of treatment and strain
27853 after 24 h, with no subsequent regrowth.
Suspended inocula of S. epidermidis. The response to
amikacin regimens was different for the two strains studied
due to different antibiotic sensitivities. The inoculum of the
highly sensitive strain V2 (amikacin MIC = 1 mg/l) was re-
duced after 6 h of exposure to amikacin by 5.2 log cfu/ml
(Aq8; figure 5) and 5.7 log cfu/ml (Aq24). After 24 h of
treatment, limited regrowth (5 X 104 cfu/ml) occurred with
regimen Aq24 but not with Aq8. However, both amikacin
regimens reduced this strain below the detection limit after
48 h of treatment.
Two additional experiments were done to elucidate fur-
ther the activity of amikacin against S. epidermidis V2. In
one experiment, suspended inocula were obtained by release
of adherent bacterial populations to determine whether the
compromised activity against adherent bacteria relates to in-
trinsically higher resistance of bacteria grown in biofilms or
whether adherently grown, released bacteria are similarly
sensitive to amikacin as populations grown in suspension.
Released adherent inocula were prepared by vortexing bio-
film-covered beads similar to the procedure used to quantify
adherent cfu. After 6 h of treatment with amikacin Aq8, the
initial inoculum was reduced by >6.2 log cfu/ml below the
detection limit. No regrowth occurred during the 48-h treat-
ment period. In another experiment, the effect of amikacin
treatment was studied against bacteria in the stationary
phase ofgrowth in PBS-So After 6 h of exposure to amikacin
Aq8, S. epidermidis V2 was killed by >5.9 log cfu/ml. In
contrast, the number of cfu remained stable over this period
in a control experiment. In summary, experiments with re-
leased or nongrowing inocula revealed results similar to the
data obtained in TSB-S using standard suspended inocula
(figure 5).
In contrast, the intermediately sensitive strain B3972 was
initially reduced by amikacin only by 2.7 (Aq8) and 3.3 log
cfu/ml (Aq24, figure 6), and regrowth to densities above the
Table 1. Change of bacterial counts in log colony-forming units (cfu) after 48-h treatment of inocula administered in suspension or as
biofilm adhering to solid or sinter glass beads.
,B-Iactam
Aq8 Aq24 (continuous infusion) Aq8 + ,B-Iactam Aq24 + ,B-Iactam
Adherent Adherent Adherent Adherent Adherent
Suspended Solid Sinter Suspended Solid Sinter Suspended Solid Sinter Suspended Solid Sinter Suspended Solid Sinter
Pseudomonas
aeruginosa
278S3 0.3 0.1 -0.3 0.2 -0.1 -0.6 -S.2 NO -1.2* -S.st NO -4.9ft -S.st NO -S.Oft
S64 -104 -0.1 -0.2 -I.S 0.3 -0.2 -4At -3.3 -2.3 -4.9t NO -S.2tt -4.8t NO -S.lft
Staph.FlocoCCliS
epidermidis
V2 -S.8t 0.8* NO -S.7t 0.7* O.S* -S.9t -S.8t -6.2t -6.lt -S.7t NO -6.0t -SAt -6.2t
B3972 0.5 NO 0.0 0.2 NO 0.1 -6.3t ND -0.9* -6.2t NO -6.0t -6.3t NO -3.9
NOTE. Aq8 = amikacin given thrice daily; Aq24 = amikacin given once daily; suspended = suspended cfu. inoculation as suspended culture; adherent.
solid = adherent cfu. inoculation as biofilm on solid glass beads; adherent. sinter = adherent cfu. inoculation as biofilm on sinter glass beads; NO = not done.
* Significantly (P < .0 I) better bactericidal activity against suspended inocula compared with adherent inocula.
t Eradicated below detection limit of 10 cfu/ml.
t Significantly (P < .0 I) better bactericidal activity of combinations compared with single-drug regimens.
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Amikacin Adherent inocula of S. epidermidis. In contrast to data
observed with suspended inocula, little initial killing was ob-
served with amikacin given as single agent against adherent
bacteria (with Aq8 and Aq24, 0.4 and 1.2 log reduction of
strain V2, respectively; with Aq8 and Aq24, 0.7 and 1.6 log
reduction of strain B3972, respectively). Subsequent doses
had no effect (figures 5 and 6). The dose response to fluclox-
acillin differed between the two strains, reflecting different
sensitivities. Adherent bacteria of the highly sensitive strain
V2 (MIC = 0.25 mg/l) were killed slowly and steadily. After
30 h of treatment, inocula were reduced below the detection
limit and no regrowth occurred (figure 5). The less-sensitive
strain B3972 (flucloxacillin MIC = 1 mg/l) showed almost
no response to treatment with a loading dose offlucIoxacillin
followed by continuous infusion of two times the MIC (0.9
log reduction over 48 h, figure 6). In additional experiments
using four-times-higher concentrations of flucIoxacillin
(eight times the MIC), response was similar to that of strain
V2, with rapid bactericidal effect followed by no regrowth.
In contrast to the synergistic effect observed during combi-
nation treatments of strain V2 on initial killing of suspended
bacteria, the combination did not kill adherent bacteria more
rapidly than flucloxacillin alone (figure 5). Combination
treatment of strain B3972 produced synergistic killing ofad-
herent bacteria, but the inocula were not yet completely era-
dicated after 48 h of treatment (figure 6, table 1).
Suspended bacteria shed from biofilm-covered glass beads
responded better to the antibiotic treatments than did adher-
ent bacteria. However, the response was less pronounced
compared with suspended bacterial cultures in the absence
ofadherent inocula (figures 5 and 6). The initial dose ofeach
regimen killed 95%-99.99% of the inocula of both strains
within 6 h. In contrast, doses administered after 24 h were
not effective « I log killing) except for the Aq24 regimen
against strain V2 (3.3 log killing followed by regrowth).
Effect ofstructure ofglass beads. Two types ofglass beads
were used to study the effect of the structure of the beads on
the bactericidal activity of amikacin, ceftazidime, and flu-
cloxacillin against adherent P. aeruginosa and S. epidermidis.
Biofilms with higher bacterial numbers adhered to the
beads with S. epidermidis compared with P. aeruginosa (table
2). The number ofcfu adhering to solid glass beads were 0.5
log (s. epidermidis) and 1.1 log (P. aeruginosa) lower than
those on sinter glass beads after 20 h of incubation in a test
tube. Twelve of these beads were used for inoculation of
each compartment.
Only minor differences were observed during antibiotic
treatment of biofilms adhering to either solid or sinter glass
beads. After 48 h of treatment, differences did not exceed I
log in the eight sets of experiments in which both types of
beads were studied (table I).
Postexposure susceptibility testing. Subpopulation analy-
sis was done during exposure of P. aeruginosa S64 to ceftazi-
dime by direct subculturing of specimens on an agar plate
containing ceftazidime one, two, or four times the MIC. No
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inoculum occurred with both regimens. Flucloxacillin alone
and in combination with Aq8 and Aq24 produced rapid ini-
tial killing and reduced the inocula of both strains after 24 h
below the detection limit with no subsequent regrowth (fig-
ures 5 and 6).
Figure 5. Effect of amikacin (thrice daily), f1ucloxacillin (load-
ing dose followed by continuous infusion), and combination of
both drugs on Staphylococcus epidermidis V2 in one-compartment
in vitro model. Significantly (P < .0 I) better initial activity was
observed in experiments with suspended inocula (colony-forming
units per milliliter [cfu/ml] in broth) compared with adherent inoc-
ula (cfu/ml bacteria shed from adherent population into culture
medium and adherent cfu per solid glass bead). Geometric means
and SD of two or three replicates are shown.
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Discussion
A novel method has been developed to expand the study
of in vitro activity of antimicrobial agents against both sus-
pended and adherent bacteria in the presence of clinically
relevant pharmacokinetic profiles. Important differences
were observed in the dose response of adherent compared
with suspended bacteria. Although amikacin was rapidly bac-
tericidal against suspended pseudomonads and staphylo-
cocci, no or only limited bactericidal effect occurred during
treatment of adherent bacteria. Similarly, the activity of cef-
tazidime was compromised when pseudomonads were ad-
herent instead of suspended. However, adherence did not
protect bacteria from the lethal activity of the ~-lactam­
aminoglycoside combination, although killing was some-
what delayed. Flucloxacillin alone was rapidly bactericidal
against suspended staphylococci and also eradicated adher-
tivity observed against adherent than against shed suspended
bacteria did not correlate with a higher percentage of resis-
tant subpopulations in the adherent bacteria. In fact, after 24
h of exposure, a significantly higher percentage of resistant
subpopulations was found in suspended bacteria shed from
biofilm (24% ofbacterial population resistant to 1 and 4 mg/l
of amikacin) compared with adherent bacteria (2.8% resis-
tant to I mg/l and 1.4% resistant to 4 mg/I; mean oftriplicate
experiments, P < .00 I). After 48 h of treatment, 43% ofshed
bacteria were resistant to 1 mg/I and 38% to 4 mg/I compared
with adherent bacterial populations with 11% resistant to 1
mg/I and 9.4% to 4 mg/I. No subpopulations of shed sus-
pended or adherent bacteria were resistant to 16 mg/I ofami-
kacin after 24 hand <0.02% at the end of the 48-h treatment
period.
Assessment ofremoval ofadherent bacteria. After the vor-
texing and washing procedure of solid glass beads initially
covered with radiolabeled bacterial biofilms, the radioactiv-
ity was reduced to 3.5% of the initial activity for S. epidermi-
dis V2 and 1.0% for P. aeruginosa 27853. The respective
results for biofilms grown on sinter glass beads were 8.1 %for
S. epidermidis B3972 and 0.2% for P. aeruginosa S64.
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NOTE. Data are log colony-forming units per glass beads (geometric
mean ± SO of replicates obtained in 12 experiments).
Table 2. Effect of structure of glass beads on bacterial inoculum
adhering as a biofilm after overnight inoculation.
Figure 6. Effect ofamikacin (once daily), flucloxacillin (loading
dose followed by continuous infusion), and combination of both
drugs on Staphylococcus epidermidis B3972 in one-compartment in
vitro model. Effect was studied in experiments with suspended inoc-
ula (colony-forming units per milliliter [cfu/ml] in broth) or adher-
ent inocula (cfu/ml bacteria shed from adherent population into
culture medium and adherent cfu per solid glass bead). Geometric
means and SD of two or three replicates are shown.
resistant subpopulation of adherent bacteria or of shed sus-
pended bacteria was detected on ceftazidime-containing
plates after 0, 6, 24, and 48 h.
Subpopulation analysis were also done during amikacin
(Aq8) treatment ofS. epidermidis V2. Lower bactericidal ac-
Pseudomonas aeruginosa
27853
S64
Staphylococcus epidermidis
V2
B3972
Solid glass beads
5.1 ± 0.5
4.7 ± 0.7
6.7 ± 0.4
6.3 ± 0.4
Sinter glass beads
6.2 ± 0.3
5.8 ± 0.2
7.1 ± 0.1
6.9 ± 0.2
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ent bacteria during exposure to eight but not two times
the MIC.
The compromised activity of antibiotics against adherent
bacteria might relate to an inoculum effect, to the develop-
ment of resistance, to altered susceptibility due to the slow
growth of the adherent populations (figure 2), or to protec-
tion of biofilm-embedded bacteria due to reduced antibiotic
penetration through the extracellular slime. In this study,
suspended inocula were adjusted to provide total numbers of
suspended bacteria within the compartments that were about
two times higher than the bacterial numbers inoculated by
adherent biofilms. Thus, lower activity against adherent inoc-
ula did not relate to an inoculum effect.
Subpopulation analysis of amikacin against S. epidermidis
V2 and ceftazidime against P. aeruginosa S64 revealed no
evidence that more resistant subpopulations existed in ad-
herent than in suspended bacteria. The comparative experi-
ments ofamikacin acting on S. epidermidis V2 in either TSB-
S or PBS-S suggest that the compromised activity against
adherent bacteria can occur during exposure of either grow-
ing or nongrowing bacteria. However, it cannot be excluded
that experiments with nongrowing suspended bacteria cul-
tured in PBS-S do not truly reflect the effect of the slow
growth rate of the adherent population within the biofilm
due to possible differences in metabolic activity of the sus-
pended and adherent cells. Nevertheless, the data obtained
support the concept that the compromised activity against
adherent bacteria relates to protection of bacteria embedded
in the biofilm. Destruction of the biofilm and release of the
adherent bacteria into suspension by vortexing revealed re-
sults similar to those of experiments using suspended over-
night cultures as inocula; however, the release of adherent
cells by destruction of the biofilm might create new meta-
bolic conditions within minutes, allowing bacteria to change
their own synthesis and catabolism.
The observations of reduced activity against shed sus-
pended bacteria do not suggest reduced susceptibility ofindi-
vidual shed organisms. Changes of the population of shed
suspended organisms during treatment represent the in-
crease of the population due to continuous release of adher-
ent bacteria from the biofilm into the culture medium minus
the ongoing killing of suspended bacteria by the antibiotics.
Thus, the intermediate treatment response of shed sus-
pended bacteria reflects the mixed effect against adherent
and suspended populations.
Rapid bactericidal activity has been demonstrated by
various in vitro methods during exposure of high inocula of
suspended bacteria to suprainhibitory concentrations of
aminoglycosides and ,B-lactams [14]. Similarly, only short
treatment periods are required to either eradicate or drasti-
cally reduce the pathogens in many animal models that pro-
vide short treatment-free periods between inoculation ofbac-
teria in suspension and the onset of therapy [16-18]. In
contrast, in vivo models of chronic infections and most se-
vere clinical infections in humans require a prolonged treat-
ment for cure. Thus, the slow bactericidal effect observed
with in vitro models for the study of antibiotic activity
against adherent bacteria might relate more closely to the
clinical situation than antibiotic exposure of suspended cul-
tures. In fact, several histologic studies suggest that popula-
tions ofadherent organisms can be found in infected patients
not only on implanted devices, but also on catheters, native
heart valves, or bone structures [7, 8, 19, 20].
Aminoglycoside treatment providing peak concentrations
ofat least 10 times the MIC has been found previously and in
this study to be bactericidal in in vitro models of infection
against suspended gram-negative and -positive bacteria [21,
22]. In the present study, however, amikacin administered
alone against adherent inocula produced no bactericidal ef-
fect after 24 h of treatment despite peak-to-MIC ratios of up
to 72. These data suggest insufficient intrinsic activity of
aminoglycosides for single-drug treatment of infections with
established populations of adherent bacteria.
The in vitro model presented here simulates antibiotic
treatment ofa bacterial infection in the absence ofany cellu-
lar or humoral host defense. However, in foreign-body infec-
tions, adherent bacteria have been found to be resistant to
killing by polymorphonuclear leucocytes [23]. Extracellular
slime found in bacterial biofilms also appears to interfere
with various host-defense mechanisms [15, 24-27]. Thus,
the model may be considered as an in vitro simulation of
antibiotic treatment of foreign-body infections.
Major differences in the in vitro activity ofantibiotics have
been observed at clinically achievable concentration profiles
against suspended and adherent bacteria. These data may
relate to clinical failures in the treatment of implant-related
infection caused by bacteria that are sensitive to the adminis-
tered antibiotics as determined by standard susceptibility
tests. Information obtained with this in vitro model may con-
tribute in concert with studies in animal models to further
development of rational hypothesis on optimal antibiotic
therapy. Ultimately such concepts need to be verified or dis-
proved by the reference standard, clinical studies.
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